The Programmed Intermittent Epidural Bolus Adrenaline Study
NCT ID: NCT03043781
Last Updated: 2018-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2017-03-20
2018-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The medicine solution used contains, in addition to bupivacain and fentanyl, adrenalin in both groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of Epidural Analgesia: Continuous Infusion Versus Programmed Intermittent Boluses
NCT02510287
Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor 2
NCT02758405
Programmed Intermittent Epidural Bolus Versus Continuous Infusion in Labour Analgesia
NCT03730753
Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women
NCT03712735
Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 2.5ml of Bupivacaine 0.25% Plus Fentanyl 8 mcg/ml
NCT03735771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is done by placing a thin plastic catheter in the epidural space in the lower back of the patient, and injecting a medicine solution usually consisting of local anesthesia and opioids.
To ensure an effective pain relief through the labor process, additional medicine solution is injected through the catheter. Traditionally, this is done by a continuous infusion, often with the addition of patient controlled boluses.
In this study the investigators investigate if maintaining the pain relief through programmed hourly intermittent boluses is more effective than continuous infusion. This is done in other studies with promising results, but the difference in this study is the addition of adrenaline to the medicine solution in order to make it more effective.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intermittent epidural bolus (IEB)
Bolus of 5 ml every hour + patient controlled extra boluses of 5 ml, maximum 3 / hour. Medicine solution is bupivacaine 1 mg/ml, fentanyl 2 mcg/ml, adrenaline 2 mcg/ml.
Intermittent epidural bolus
Intermittent bolus 5 ml every hour
Continuous epidural infusion (CEI)
Continuous epidural infusion of 5 ml / hour + patient controlled extra boluses of 5 ml, maximum 3 / hour. Medicine solution is bupivacaine 1 mg/ml, fentanyl 2 mcg/ml, adrenaline 2 mcg/ml.
Continuous epidural infusion
Continuous infusion, 5 ml/h
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous epidural infusion
Continuous infusion, 5 ml/h
Intermittent epidural bolus
Intermittent bolus 5 ml every hour
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA group 1 and 2
* 0 or 1 previous births
* Must be at least 18 years of age.
* Singleton pregnancy
* Active labor
* Signed informed consent and expected cooperation of the patient
Exclusion Criteria
* Adverse reactions to local anesthetics or synthetic opioids
* Body height below 150 cm
* Gestational age below 37 weeks, 0 days
* Any contraindication to epidural catheter placement (e.g. patients with coagulopathy, infection in area etc)
* Pre-eclampsia
* Sound reason by the investigator to suspect patient non-compliance (e.g. with use of PCEA)
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Akershus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vegard Dahl
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vegard Dahl, MD, Dr. Med.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Akershus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akershus UH
Lørenskog, Akershus, Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
George RB, Allen TK, Habib AS. Intermittent epidural bolus compared with continuous epidural infusions for labor analgesia: a systematic review and meta-analysis. Anesth Analg. 2013 Jan;116(1):133-44. doi: 10.1213/ANE.0b013e3182713b26. Epub 2012 Dec 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-004397-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.